Corbus Pharmaceuticals Holdings, Inc.
CRBPCorbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare, inflammatory, and fibrotic diseases. The company's pipeline emphasizes its expertise in cannabinoid-based medicines, with particular interest in conditions such as cystic fibrosis, dermatomyositis, and other inflammatory disorders. Corbus aims to deliver novel treatments targeting underlying disease mechanisms to improve patient outcomes.
Company News
Corbus Pharmaceuticals has priced a public offering of 4,744,231 common stock shares and pre-funded warrants, raising approximately $75 million to fund clinical development and corporate purposes.
Corbus Pharmaceuticals plans to raise approximately $75 million through a public offering of 4,744,231 common stock shares and pre-funded warrants, with proceeds intended to fund clinical development and working capital.
Corbus Pharmaceuticals (CRBP) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Use these tips to buy penny stocks in December The post Buying Penny Stocks in December? 3 Top Tips to Profit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Important events on the horizon could push these biotech stocks higher or press them further into the dirt.
